1. Home
  2. ETNB vs TH Comparison

ETNB vs TH Comparison

Compare ETNB & TH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • TH
  • Stock Information
  • Founded
  • ETNB 2018
  • TH 1978
  • Country
  • ETNB United States
  • TH United States
  • Employees
  • ETNB N/A
  • TH N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • TH Hotels/Resorts
  • Sector
  • ETNB Health Care
  • TH Consumer Discretionary
  • Exchange
  • ETNB Nasdaq
  • TH Nasdaq
  • Market Cap
  • ETNB 864.2M
  • TH 932.0M
  • IPO Year
  • ETNB 2019
  • TH N/A
  • Fundamental
  • Price
  • ETNB $6.31
  • TH $10.65
  • Analyst Decision
  • ETNB Buy
  • TH Hold
  • Analyst Count
  • ETNB 7
  • TH 3
  • Target Price
  • ETNB $30.33
  • TH $11.50
  • AVG Volume (30 Days)
  • ETNB 1.3M
  • TH 440.5K
  • Earning Date
  • ETNB 02-27-2025
  • TH 03-12-2025
  • Dividend Yield
  • ETNB N/A
  • TH N/A
  • EPS Growth
  • ETNB N/A
  • TH N/A
  • EPS
  • ETNB N/A
  • TH 0.87
  • Revenue
  • ETNB N/A
  • TH $428,804,000.00
  • Revenue This Year
  • ETNB N/A
  • TH N/A
  • Revenue Next Year
  • ETNB N/A
  • TH N/A
  • P/E Ratio
  • ETNB N/A
  • TH $12.17
  • Revenue Growth
  • ETNB N/A
  • TH N/A
  • 52 Week Low
  • ETNB $5.99
  • TH $6.11
  • 52 Week High
  • ETNB $16.63
  • TH $11.84
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 31.27
  • TH 69.11
  • Support Level
  • ETNB $5.99
  • TH $9.35
  • Resistance Level
  • ETNB $6.65
  • TH $11.10
  • Average True Range (ATR)
  • ETNB 0.40
  • TH 0.39
  • MACD
  • ETNB -0.14
  • TH 0.09
  • Stochastic Oscillator
  • ETNB 15.70
  • TH 74.24

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

Share on Social Networks: